XTX Topco’s InMed Pharmaceuticals INM Stock Holding History

XTX Topco’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-891	Closed	-$4.73K	–	2321
2024 Q2	$4.73K	Buy	+891	New	+$5.09K	﹤0.01%	1750

Other funds holding INM

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

XTX Topco's INM Position: Q3 2024 in Review

XTX Topco sold out of InMed Pharmaceuticals (INM) in Q3 2024, closing a stake of 891 shares — an estimated $4.73K sold.

XTX Topco first reported a position in INM in Q2 2024 and held it in 1 quarter. The position peaked at $4.73K in Q2 2024. 13 funds tracked by Wall St. Rank hold INM as of Q3 2024.

XTX Topco reported no remaining InMed Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 891 InMed Pharmaceuticals shares in Q3 2024, an estimated $4.73K.
XTX Topco first reported a position in InMed Pharmaceuticals in Q2 2024 and held it in 1 quarter.
XTX Topco's InMed Pharmaceuticals position peaked at $4.73K in Q2 2024.
13 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.